Scarica l'app Stockscreener
4.82
2.23%
-0.12
Dopo l'orario di chiusura:
4.83
0.010
+0.21%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.94
Aprire:
$4.95
Volume 24 ore:
261.29K
Relative Volume:
0.50
Capitalizzazione di mercato:
$90.45M
Reddito:
$109.43M
Utile/perdita netta:
$5.13M
Rapporto P/E:
18.50
EPS:
0.2606
Flusso di cassa netto:
$18.91M
1 W Prestazione:
+0.00%
1M Prestazione:
-24.88%
6M Prestazione:
-68.60%
1 anno Prestazione:
-58.54%
Intervallo 1D:
$4.7812
$5.06
Intervallo di 1 settimana:
$4.71
$5.12
Portata 52W:
$4.57
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Nome
Optimizerx Corp
Settore
Industria
Telefono
248-651-6558
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, BTSG, TEM, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
4.82 | 92.70M | 109.43M | 5.13M | 18.91M | 0.2606 |
VEEV
Veeva Systems Inc
|
158.56 | 26.14B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
60.32 | 11.34B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.64 | 8.29B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
87.33 | 7.39B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
52.98 | 4.28B | 646.34M | -512.40M | 202.76M | -6.6871 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-02-02 | Ripresa | B. Riley Securities | Buy |
| 2022-11-01 | Iniziato | Stifel | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2021-10-18 | Ripresa | B. Riley Securities | Buy |
| 2021-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-01-03 | Iniziato | William Blair | Outperform |
Mostra tutto
Optimizerx Corp Borsa (OPRX) Ultime notizie
OptimizeRx Q1 earnings call highlights - MSN
OptimizeRx Corp. and DeepIntent Announce First Integration of EHR Network into Healthcare Advertising Platform - Quiver Quantitative
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network - The Manila Times
OptimizeRx Corp. Integrates Proprietary Electronic Health Record Network Into DeepIntent Healthcare Advertising Platform - marketscreener.com
OPRX Technical Analysis | Trend, Signals & Chart Patterns | OPTIMIZERX CORP (NASDAQ:OPRX) - ChartMill
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds - qz.com
OptimizeRx Corp. Sees Valuation Upgrade Amid Positive Financial Trends and High Institutional Confidence - Markets Mojo
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold? - sharewise.com
OptimizeRx Corp stock (US6837631027): earnings momentum and buyback plan put focus back on digital h - AD HOC NEWS
OptimizeRx (OPRX) CCO logs Form 4 tax-withholding share dispositions - Stock Titan
OptimizeRx (OPRX) CEO has 5,219 shares withheld to cover RSU tax - Stock Titan
OptimizeRx's Q4 Beat: A Closer Look at the Numbers - Kavout
OptimizeRx Corp stock (US6837631027): earnings beat, buyback plan and volatile AI-health rally - AD HOC NEWS
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead? - Yahoo Finance
Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates - Yahoo Finance
OptimizeRx Corp stock (US6837631027): Bank note points to valuation reset - AD HOC NEWS
OptimizeRx (OPRX) Q1 2026 Earnings Transcript - The Globe and Mail
OptimizeRx Secures New Credit Facility to Boost Flexibility - The Globe and Mail
OptimizeRx Expands EHR Advertising Reach With New DSP Integration - qz.com
OptimizeRx (NASDAQ: OPRX) cuts Q1 loss as margins improve and debt refinanced - Stock Titan
Stifel cuts OptimizeRx stock price target on weaker guidance - Investing.com UK
B. Riley Adjusts Price Target on OptimizeRx to $10 From $11, Maintains Buy Rating - marketscreener.com
Stifel cuts OptimizeRx stock price target on weaker guidance By Investing.com - Investing.com Australia
OptimizeRx Corporation (NASDAQ:OPRX) Q1 2026 Earnings Call Transcript - Insider Monkey
OPRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance - The Manila Times
Earnings call transcript: OptimizeRx Q1 2026 beats estimates, stock rises - Investing.com UK
OptimizeRx Exceeds Expectations with Strong Q1 Growth - Intellectia AI
OptimizeRx Q1 Earnings Call Highlights - sharewise.com
Earnings Call Summary | OptimizeRx(OPRX.US) Q1 2026 Earnings Conference - Moomoo
OptimizeRx Corp. (OPRX) surpasses Q1 earnings and revenue estimates - MSN
OptimizeRx Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: OptimizeRx Q1 2026 beats estimates, stock rises By Investing.com - Investing.com Nigeria
Optimizerx Corp enters credit agreement with Fifth Third Bank on May 7, 2026SEC filing - marketscreener.com
OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
OPTIMIZERx earnings beat by $0.13, revenue topped estimates - Investing.com
OptimizeRx Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance - ChartMill
OptimizeRx Corporation (OPRX) Releases Q1 2026 Earnings: Revenue Down but Beats; EPS Miss - Quiver Quantitative
OptimizeRx (Nasdaq: OPRX) posts Q1 2026 results and secures $35M credit facility - Stock Titan
Press Release: OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance - Moomoo
OptimizeRx Corporation Launches Programmatic Access to Authenticated EHR Advertising - marketscreener.com
Optimizerx launches programmatic access to authenticated EHR advertising at scale - marketscreener.com
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale - marketscreener.com
Pharma ads go programmatic inside doctors' EHRs via OptimizeRx - Stock Titan
OptimizeRx (OPRX) price target decreased by 40.41% to 14.79 - MSN
OptimizeRx Corp expected to post breakeven results a shareEarnings Preview - TradingView
Optimizerx Corp Azioni (OPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Optimizerx Corp Azioni (OPRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Stelmakh Edward | Chief Finance & Strat Officer |
Dec 19 '25 |
Sale |
13.51 |
1,388 |
18,752 |
126,830 |
| Silvestro Stephen L | Chief Executive Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
6,546 |
0 |
195,462 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
3,928 |
0 |
94,526 |
| Besch Doug | Chief Product & Tech Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
1,964 |
0 |
71,536 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
92,550 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
2.63%
3.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):